CM-7 Drug Free Workplace and Workforce



In addition to requirements of the Drug Free Workplace Act of 1988 which apply to all employees engaged in the performance of a federal grant or contract, the Department of Defense has issued regulations which specifically apply to employees engaged in the performance of a Department of Defense contract which are provided below.

Covered employees include those employees engaged in the performance of Department of Defense contracts as follows:

For those Department of Defense contracts to which these regulations apply, the following specific conditions or appropriate alternatives apply:

"(1) Employee assistance programs emphasizing high level direction, education, counseling, rehabilitation, and coordination with available community resources (which shall be as provided through any LSUHSC Employee Assistance Program);
"(2) Supervisory training to assist in identifying and addressing illegal drug use by Contractor employees (which shall be as provided through the Office of Human Resource Management);
"(3) Provision for self-referrals as well as supervisory referrals to treatment with maximum respect for individual confidentiality consistent with safety and security issues (which shall be as provided through the provisions of any LSUHSC Employee Assistance Program and this Policy Statement);
"(4) Provision for identifying illegal drug users, including testing on a controlled and carefully monitored basis. Employee drug testing programs shall be established taking account of the following:
"(c) Contractor programs shall include the following, or appropriate alternative.
"(ii) In addition, the Contractor may establish a program for employee drug testing--
"(A) When there is a reasonable suspicion that an employee uses illegal drugs; or
"(B) When a employee has been involved in an accident or unsafe practice;
"(C) As a part of or as a follow-up to counseling or rehabilitation for illegal drug use;
"(D) As a part of a voluntary employee drug testing program.
"(iii) The Contractor may establish a program to test applicants for employment for illegal drug use.
"(iv) For the purpose of administering this clause, testing for illegal drugs may be limited to those substances for which testing is prescribed by section 2.1 of Subpart B of the Mandatory Guidelines for Federal Workplace Drug Testing Program," (53 FR 11980 (April 11, 1988)) issued by the Department of Health and Human Services.
"(d) Contractors shall adopt appropriate personnel procedures to deal with employees who are found to be using drugs illegally. Contractors shall not allow any employee to remain on duty or perform in a sensitive position who is found to use illegal drugs until such time as the contractor, in accordance with procedures established by the contractor, determines that the employee may perform in such a position.
"(e) The provisions of this clause pertaining to drug testing programs shall not apply to the extent they are inconsistent with state or local law, or with an existing collective bargaining agreement; provided that with respect to the latter, the Contractor agrees that those issues that are in conflict will be a subject of negotiation at the next collective bargaining session."

Listed below are substance abuse programs offered by professional organizations or societies for specific groups.

Allied Health Professions Students
Office for Student Affairs
LSUHSC - Shreveport
1501 Kings Hwy
Shreveport, LA 71130-3932
Office for Student Affairs
LSU School of Medicine
1501 Kings Highway
Shreveport, La. 71130
Ms. Betty Anderson
Nursing Services
1501 Kings Highway
LSU Health Sciences Center
Shreveport, La. 71130
Phone: 674-7397
Impaired Physicians Program
LSU School of Medicine, Shreveport
1501 Kings' Highway
Shreveport, LA 70130
Phone: 674-7656
Employees - LSU Health Sciences Center
Employee Assistance Program
LSU Health Sciences Center - Shreveport
1501 Kings Hwy
Shreveport, LA 71130-3932


An Employee Assistance Program is being established at LSU Health Sciences Center to assist employees who may be suffering from substance abuse or addiction to controlled substances. Services to be provided are described below:

INFORMATION AND REFERRAL: A counselor who will provide patient information on professional agencies and individuals in the community who are qualified to assist the patient in the resolution of his/her problem.

ASSESSMENT/PROBLEM CLARIFICATION: The E.A.P. counselor during an initial assessment will clarify problem areas and identify clinical needs by psychosocial histories and individual/family interviews. Identification of problems and/or clinical issues will be made with recommendations that can resolve the problem when possible. If resolution is not possible then referral to an appropriate resource which will assist the patient in the resolution of their problem will be made.

SHORT TERM COUNSELING: The counselor will provide short term counseling of a problem clarifying/solving nature to assist patients with problems which can adequately be resolved and/or addressed in 1 to 5 counseling sessions.

EXCEPTIONS: Exceptions to the foregoing will be made when it is deemed in the patient's interest to be referred upon initial contact and/or assessment.

MEDICAL INSURANCE: Employees should check their hospitalization insurance to determine their policy's coverage for mental health counseling. This might be of some limited assistance if there is a need for long term counseling.

PATIENT ADVOCACY: The counselor will serve in the capacity as advocate for the patient in obtaining services as appropriate to his/her needs, serve as a liaison for the patient on an as needed basis and additionally provide follow-up on the referral. To facilitate expeditious and appropriate referrals to community services, a current file of all potential service providers will be maintained.

SUPERVISORY AND DRUG SCREEN REFERRALS: The counselor operating under the guidelines governing confidentiality will provide a clinical assessment and referral to the patient and provide to LSUHSC only information regarding the patient's level of cooperation and participation in the E.A.P. services and recommended referral only after a release of information has been obtained from the patient. After obtaining a release of information, monthly follow up reports may be provided to management.


Patient records will be handled in accordance with the confidentiality requirements of PL93-282 and the Federal regulations of 42 CFR Part 21 (section 2.11n) and P193-579 (Privacy Act). Treatment records will never become part of an employee's personnel and medical files, but will remain available only to the E.A.P. staff. Records will be stored securely, and professional standards of content, legibility and timeliness will be maintained.

Signed: John C. McDonald, M.D. Chancellor
June 1, 2001

Copyright (c) 2018 Medical Communication. All Rights Reserved.